Cancer Immunohistogram Representing Cancer-Immunity Cycle by Immunohistochemistry Predicts the Efficacy of Immune Checkpoint Inhibitors in Urological Cancer Patients

Scientists developed an immunohistogram representing an individual cancer-immunity cycle based on immunohistochemical analyses and evaluated its ability to predict the efficacy of immune checkpoint inhibitors in patients with urothelial carcinoma and renal cell carcinoma.